Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
AMLX
MBX
Add up to 3 more stocks
AMLX
Amylyx Pharmaceuticals, Inc.
+0.94%
$28.04+0.26Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$3.12B
52W Range
$10.83 - $41.14
MBX
MBX Biosciences, Inc. Common Stock
-2.77%
$56.92-1.62Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$2.71B
52W Range
$12.94 - $72.64
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 13.04 | 6.62 |
| P/S Ratio | N/A | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% |
| ROE | -63.6% | -25.5% |
| ROA | -57.5% | -23.9% |
| ROIC | -66.6% | -28.6% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 12.12 | 18.08 |
| Quick Ratio | 12.12 | 18.08 |
| Debt/Equity | 0.02 | 0.01 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.